U.S. markets open in 5 hours 2 minutes
  • S&P Futures

    +21.75 (+0.56%)
  • Dow Futures

    +152.00 (+0.49%)
  • Nasdaq Futures

    +66.00 (+0.56%)
  • Russell 2000 Futures

    +12.10 (+0.68%)
  • Crude Oil

    +0.64 (+0.58%)
  • Gold

    +14.80 (+0.80%)
  • Silver

    +0.35 (+1.62%)

    +0.0067 (+0.64%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +0.04 (+0.14%)

    +0.0069 (+0.55%)

    -0.3130 (-0.24%)

    +984.56 (+3.35%)
  • CMC Crypto 200

    +7.52 (+1.12%)
  • FTSE 100

    +53.08 (+0.72%)
  • Nikkei 225

    +262.49 (+0.98%)

A Phibro Animal Health Corporation (NASDAQ:PAHC) insider increased their holdings by 33% last year

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Looking at Phibro Animal Health Corporation's (NASDAQ:PAHC ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

View our latest analysis for Phibro Animal Health

The Last 12 Months Of Insider Transactions At Phibro Animal Health

The Independent Non-Executive Director E. Corcoran made the biggest insider purchase in the last 12 months. That single transaction was for US$118k worth of shares at a price of US$23.68 each. That means that even when the share price was higher than US$19.95 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. E. Corcoran was the only individual insider to buy during the last year.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!


There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Phibro Animal Health Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Phibro Animal Health insiders own 50% of the company, currently worth about US$405m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At Phibro Animal Health Tell Us?

It doesn't really mean much that no insider has traded Phibro Animal Health shares in the last quarter. However, our analysis of transactions over the last year is heartening. It would be great to see more insider buying, but overall it seems like Phibro Animal Health insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Phibro Animal Health. For instance, we've identified 3 warning signs for Phibro Animal Health (2 are a bit concerning) you should be aware of.

Of course Phibro Animal Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.